Chemed Corporation

NYSE CHE

Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 440.61 M

Chemed Corporation EBITDA is USD 440.61 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 15.47% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 381.58 M, a -6.86% change year over year.
Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 409.69 M, a -11.09% change year over year.
Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 460.77 M, a 17.02% change year over year.
Chemed Corporation EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 393.75 M, a 35.48% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NYSE: CHE

Chemed Corporation

CEO	Mr. Kevin J. McNamara
IPO Date	May 3, 1973
Location	United States
Headquarters	255 East Fifth Street
Employees	15,087
Sector	Health Care
Industries Senior Care Telehealth

Description

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Key trends

Past 5 years